Pilot Study of a Smartphone-Based Vaping Cessation Program

Launched by PIVOT HEALTH TECHNOLOGIES INC. · Nov 29, 2022

Keywords

ClinConnect Summary

This is a prospective, open label, single center clinical study conducted with IRB approval enrolling up to 100 adult participants who report daily vaping. The study will be performed remotely on an ambulatory basis.

Participants will be asked to set up and use the "Pivot for Vape" program. The program includes an app, moderated online community, and SMS-based coaching with a tobacco treatment specialist. The study duration is 52 weeks, with the estimated active time using the program of up to 6 months and the time thereafter as follow-up. Participants will receive online questionnaires at...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Current daily nicotine vape/e-cigarette user for at least the past 30 days
• • Plans to quit vaping in the next 6 months
• • Reports average VSPD ≥ 5
• • Interested in working with a vape cessation coach via SMS text
• • Resident of the United States
• • Able to read and comprehend English
• • Owns and uses a smartphone compatible with the study app (iPhone 5 and above with operating system iOS 12 and above, or, Android 7.0 and above with operating system Android 7.0 and above)
• • Has daily internet access on smartphone
• • Comfortable downloading and using smartphone apps
• • Willing to sign the Informed Consent Form (ICF)
• Exclusion Criteria:
• • Using other vaping cessation apps, coaching, classes, or quit programs at entry
• • Currently using cigarettes
• • If previous cigarette smoker, need to have quit smoking at least 3 months ago (self-report)
• • Failure to provide contact or collateral information, and/or failure to verify email address
• • Participation in a previous study sponsored by Pivot Health Technologies Inc. (formerly Carrot Inc.)

Trial Officials